The stigma associated with gestational diabetes mellitus: A scoping review

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 444 KB, PDF-dokument

  • Emma Davidsen
  • Helle Terkildsen Maindal
  • Morten Hulvej Rod
  • Kasper Olesen
  • Molly Byrne
  • Damm, Peter
  • Karoline Kragelund Nielsen

Background: Gestational diabetes mellitus (GDM) affects an increasing number of pregnant women globally. Although studies have identified psychosocial ramifications associated with GDM, stigma in the form of experienced discrimination and self-blame and its consequences have received limited attention. Our objective was to examine the current evidence on stigma, as experienced among women with GDM, including the potential adverse consequences hereof. Methods: A scoping review was conducted with citations retrieved from the databases MEDLINE, CINAHL, EMBASE and, PsycINFO. Studies published before 15 June 2022, when the search was conducted, were included. Findings: We identified 1388 citations and included 44 in the review. We found that women with GDM may experience stigma in the form of overt discrimination from healthcare personnel and relatives, and in the form of internalised stigma, such as guilt and shame. Identified consequences include avoidance of screening, not following dietary recommendations nor reporting blood glucose readings, social isolation, and poor mental wellbeing. No estimates of stigma prevalence were identified. Interpretation: Existing evidence shows that women with GDM report stigma, which may affect both their mental and physical health. Further investigations into the prevalence of stigma and long-term consequences of stigma are much needed. Funding: The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

OriginalsprogEngelsk
Artikelnummer101614
TidsskriftEClinicalMedicine
Vol/bind52
ISSN2589-5370
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
ED, KKN, HTM, MHR, and KO are employed at Steno Diabetes Center Copenhagen, a public hospital and research institution under the Capital Region of Denmark, which is partly funded by a grant from the Novo Nordisk Foundation. Funding for ED's PhD was also received from Aarhus University, Denmark. The funders had no role in any part of this study. PD is chair of DSMB for the EMERGE trial: A Randomised Placebo Controlled Trial of the effectiveness of Early MEtformin Care in the Reduction of Gestational Diabetes Mellitus Effects (EMERGE). This is not paid. MB declare no conflict of interests.

Funding Information:
We would like to thank Lauge Neimann Rasmussen for providing valuable feedback on the search strategy and Anne Husted Henriksen for aiding with the quality appraisal of included citations. Funding was received from Department of Public Health, Aarhus University, Denmark, and Steno Diabetes Center Copenhagen, a public hospital and research institution under the Capital Region of Denmark, which is partly funded by a grant from the Novo Nordisk Foundation.

Publisher Copyright:
© 2022 The Authors

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 319806910